Experience

Earendil Labs Announces Worldwide Exclusive License Agreement With Sanofi

April 17, 2025

Cooley advised Earendil Labs, an artificial intelligence-driven biotech company affiliated with Helixon Therapeutics, in connection with Earendil Labs’ license agreement with Sanofi for two potential first-in-class bispecific antibodies in the field of autoimmune and inflammatory bowel diseases.

Read more

Related contacts

Geoffrey Spolyar
Partner, Boston
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Zack Gong
Associate, Shanghai
Dr. Xiaozhen (Shawn) Yu
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

Puhe BioPharma Announces Global License Agreement With Bayer

March 26, 2025

Cooley advised Puhe BioPharma, a biotechnology company dedicated to the research and development of innovative small-molecule precision therapeutics, on its global license agreement with Bayer for Puhe BioPharma’s oral, small-molecule protein arginine methyltransferase 5 inhibitor that selectively targets metabolic enzyme 5’-deoxy-5’-methylthioadenosine phosphorylase-deleted tumors.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Freddy Yip
Associate, Hong Kong
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Jiangsu Hengrui Pharmaceuticals Announces License Agreement With Merck

March 25, 2025

Cooley advised Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma), a global pharmaceutical company focused on scientific and technological innovation, on its exclusive license agreement with Merck (NYSE: MRK), known as MSD outside of the US and Canada, for HRS-5346, an investigational oral small molecule lipoprotein(a), or Lp(a), inhibitor currently being evaluated in a phase 2 clinical trial in China.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Jiqiang Lin
Associate, New York
Andrew Epstein
Special Counsel, Seattle
Zhijing Yu
Associate, Singapore
David Burns
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Russell Anderson
Partner, London
Megan Browdie
Partner, Washington, DC
Steve Przesmicki
Partner, San Diego

Related Practices & Industries

DataStax Announces Acquisition by IBM

February 25, 2025

Cooley advised DataStax, an artificial intelligence (AI) and data solution provider, on its acquisition by IBM (NYSE: IBM), a provider of global hybrid cloud and AI solutions and consulting expertise.

Read more

Related contacts

Rishab Kumar
Partner, Palo Alto
David Segre
Of Counsel, Palo Alto
Grigor Lynch
Associate, Colorado
Alessandra Murata
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Caitlin Courtney
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Michael Bergmann
Partner, Washington, DC
Wendy Brenner
Partner, Palo Alto
Megan Browdie
Partner, Washington, DC
Annie Froehlich
Partner, Washington, DC
Stella Sarma
Partner, Brussels
David Wilson
Partner, London
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Tiffany Allen
Associate, Palo Alto
Harry Calkin
Associate, London
Queenie Chen
Associate, Palo Alto
David Dalton
Associate, Santa Monica
Cristina DeBiase
Associate, Boston
Juan Pablo González
Associate, Palo Alto
Cameron Gyorffy
Associate, Santa Monica
Kelley Harrington
Associate, Chicago
Josh Himmelstern
Associate, San Diego
Katie Kaufman
Associate, Boston
Joseph J. Kim
Associate, Palo Alto
Eerik Kukebal
Associate, London
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles
Breanna Qin
Associate, Palo Alto
Katie Stevens
Associate, Palo Alto
John Alec Stouras
Associate, Palo Alto
Nicholas Yacoubian
Associate, Palo Alto
Christy Fairlie
Paralegal Specialist, Reston
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Keros Therapeutics Announces Ex-China Global License Agreement With Takeda

December 3, 2024

Cooley advised Keros Therapeutics (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of proteins, on its exclusive global development and commercialization license agreement with Takeda Pharmaceuticals to advance elritercept.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Ryan Sansom
Partner, Boston
Marc Recht
Partner, Boston
David Burns
Special Counsel, Washington, DC
Navya Dasari
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Bartholomäus Regenhardt
Associate, Brussels
Stella Sarma
Partner, Brussels

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

Virginia

Rankings and accolades

Super Lawyers Rising Stars: Antitrust (2018-2022)

Best Lawyers: Antitrust Law, Ones to Watch

Legal 500: Merger Control (2021)

Memberships and affiliations

American Bar Association (ABA)